Marshall Wace’s Aesthetic Medical International Holdings AIH Stock Holding History

Marshall Wace’s Portfolio AIH Stock Details AIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-84,241	Closed	-$338K	–	4388
2021 Q3	$338K	Buy	84,241 +6,039	+8%	+$29.8K	﹤0.01%	2591
2021 Q2	$622K	Buy	78,202 +50,868	+186%	+$380K	﹤0.01%	2035
2021 Q1	$201K	Buy	+27,334	New	+$177K	﹤0.01%	2261

Other funds holding AIH

ITVII

IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace's AIH Position: Q4 2021 in Review

Marshall Wace sold out of Aesthetic Medical International Holdings (AIH) in Q4 2021, closing a stake of 84,241 shares — an estimated $338K sold.

Marshall Wace first reported a position in AIH in Q1 2021 and held it in 3 quarters. The position peaked at $622K in Q2 2021. 5 funds tracked by Wall St. Rank hold AIH as of Q4 2021.

Marshall Wace reported no remaining Aesthetic Medical International Holdings position as of Q4 2021 after selling out during the quarter.
Marshall Wace sold 84,241 Aesthetic Medical International Holdings shares in Q4 2021, an estimated $338K.
Marshall Wace first reported a position in Aesthetic Medical International Holdings in Q1 2021 and held it in 3 quarters.
Marshall Wace's Aesthetic Medical International Holdings position peaked at $622K in Q2 2021.
5 funds tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.